Beckman Coulter Inc., a Brea maker of medical testing products, reported fourth-quarter results Thursday that surpassed Wall Street’s expectations and reaffirmed its 2010 profit outlook.
Beckman said its profit before special items came in at $91.8 million, above analysts’ projection of $89.8 million.
The company makes instruments and supplies used by medical laboratories and researchers.
Fourth-quarter revenue rose 22% to $989.6 million, with $120.2 million of that coming via Beckman’s $800 million buy last year of Olympus Corp.’s medical diagnostic business.
Wall Street was looking for Beckman to have revenue of $963.2 million in the fourth quarter.
Beckman didn’t offer a forecast for the current quarter in its release. Analysts expect it to post a profit of $62 million on revenue of $873.9 million in the first quarter.
For 2010, Beckman said it expected a profit of $313.7 million to $324.4 million, in line with analysts’ expectations of $320.9 million on the higher end.
Beckman sees sales for 2010 coming in at $3.8 billion to $3.9 billion, including $480 million to $500 million from Olympus, and exceeding Wall Street’s projection of $3.78 billion.
